The 2007 WHO classification of tumours of the central nervous system
The fourth edition of the World Health Organization (WHO) classification of tumours of the
central nervous system, published in 2007, lists several new entities, including angiocentric …
central nervous system, published in 2007, lists several new entities, including angiocentric …
Malignant gliomas in adults
Malignant gliomas, the most common type of primary brain tumor in adults, are associated
with disproportionate cancer-related morbidity and mortality. Recently, there have been …
with disproportionate cancer-related morbidity and mortality. Recently, there have been …
Central nervous system cancers, version 3.2020, NCCN clinical practice guidelines in oncology
The NCCN Guidelines for Central Nervous System (CNS) Cancers focus on management of
adult CNS cancers ranging from noninvasive and surgically curable pilocytic astrocytomas …
adult CNS cancers ranging from noninvasive and surgically curable pilocytic astrocytomas …
Therapy for diffuse astrocytic and oligodendroglial tumors in adults: ASCO-SNO guideline
NA Mohile, H Messersmith, NTN Gatson, AF Hottinger… - 2022 - academic.oup.com
Purpose To provide guidance to clinicians regarding therapy for diffuse astrocytic and
oligodendroglial tumors in adults. Methods ASCO and the Society for Neuro-Oncology …
oligodendroglial tumors in adults. Methods ASCO and the Society for Neuro-Oncology …
EANO guideline for the diagnosis and treatment of anaplastic gliomas and glioblastoma
M Weller, M Van Den Bent, K Hopkins, JC Tonn… - The lancet …, 2014 - thelancet.com
This guideline provides recommendations for diagnostic and therapeutic procedures for
patients with malignant gliomas. We differentiate evidence-based standards from …
patients with malignant gliomas. We differentiate evidence-based standards from …
[HTML][HTML] CGCG clinical practice guidelines for the management of adult diffuse gliomas
Abstract The Chinese Glioma Cooperative Group (CGCG) Guideline Panel for adult diffuse
gliomas provided recommendations for diagnostic and therapeutic procedures. The Panel …
gliomas provided recommendations for diagnostic and therapeutic procedures. The Panel …
Phase III trial of chemoradiotherapy for anaplastic oligodendroglioma: long-term results of RTOG 9402
G Cairncross, M Wang, E Shaw, R Jenkins… - Journal of clinical …, 2013 - ascopubs.org
Purpose Anaplastic oligodendrogliomas, pure (AO) and mixed (anaplastic oligoastrocytoma
[AOA]), are chemosensitive, especially if codeleted for 1p/19q, but whether patients live …
[AOA]), are chemosensitive, especially if codeleted for 1p/19q, but whether patients live …
Primary brain tumours in adults
Important advances have been made in the understanding and management of adult
gliomas and primary CNS lymphomas—the two most common primary brain tumours …
gliomas and primary CNS lymphomas—the two most common primary brain tumours …
IDH mutation status and role of WHO grade and mitotic index in overall survival in grade II–III diffuse gliomas
A Olar, KM Wani, KD Alfaro-Munoz, LE Heathcock… - Acta …, 2015 - Springer
Diffuse gliomas are up till now graded based upon morphology. Recent findings indicate
that isocitrate dehydrogenase (IDH) mutation status defines biologically distinct groups of …
that isocitrate dehydrogenase (IDH) mutation status defines biologically distinct groups of …
MGMT promoter methylation in malignant gliomas: ready for personalized medicine?
M Weller, R Stupp, G Reifenberger… - Nature Reviews …, 2010 - nature.com
The DNA repair enzyme O 6-methylguanine-DNA methyltransferase (MGMT) antagonizes
the genotoxic effects of alkylating agents. MGMT promoter methylation is the key mechanism …
the genotoxic effects of alkylating agents. MGMT promoter methylation is the key mechanism …